sábado, 14 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 6, 2026

The AI Build-Out Is Just Getting Started

View original at finance.yahoo.com
The AI Build-Out Is Just Getting Started In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributor Rachel Warren talks with Jay Jacobs, U.S…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Thematic ETFs give retail investors more precise exposure to investment themes than traditional sector funds

    60% confidence
  • Despite massive capex spending by major LLM providers, they cannot keep up with AI demand

    60% confidence
  • A $1,000 investment in Netflix at the time of the December 17, 2004 Stock Advisor recommendation would be worth $443,191 as of June 6, 2026

    60% confidence
  • Market narrative has shifted from fear of AI capex over-investment to concern about potential under-investment

    60% confidence
  • Stock Advisor has a track record of beating the S&P 500 by 4x

    60% confidence
  • Token consumption last year grew 17 times — not 17%, but 17x

    60% confidence
  • Agentic AI, physical robotics, and tokenization are key themes for investor portfolios in 2026

    60% confidence
  • A $1,000 investment in Nvidia at the time of the April 15, 2005 Stock Advisor recommendation would be worth $1,258,838 as of June 6, 2026

    60% confidence
  • The AI infrastructure boom is still in its infancy

    60% confidence
  • BlackRock was not among the 10 best stocks identified by Motley Fool Stock Advisor analysts for current purchase

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,580 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
The AI Build-Out Is Just Getting Started — Source | Via News | pt.via.news